AnHeart Therapeutics
3 known investors
Find your way into AnHeart Therapeutics
Sign up to see every warm intro you have to AnHeart Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AnHeart Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biopharma, acquired by Nuvation Bio (葆元医药)
Investors · 3
Decheng Capitallisted by Decheng CapitalSilicon Valley
How we know: Decheng Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BDec 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does AnHeart Therapeutics do?
- Biopharma, acquired by Nuvation Bio (葆元医药)
- Who are AnHeart Therapeutics's investors?
- AnHeart Therapeutics's investors include Cenova Capital, Decheng Capital, Vertex Ventures China.
